AmeriCann, Inc.

AmeriCann, Inc.

ACAN
AmeriCann, Inc.US flagOther OTC
0.00
USD
- -
- -
2,439.00Market Cap
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
TTM
Revenue per Share
- -
- -
- -
0.01
- -
- -
- -
- -
0.02
0.08
0.12
0.1
0.05
0.03
Basic EPS, GAAP
- -
- -
-0.08
-0.1
-0.13
-0.15
-0.22
-0.21
-0.03
-0.04
-0.01
- -
-0.05
-0.1
Free Cash Flow per Basic Share
- -
- -
-0.05
-0.05
-0.04
-0.12
-0.15
-0.35
0.01
-0.02
0.02
0.01
-0.05
-0.06
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.01
-0.01
-0.12
-0.22
-0.35
-0.46
-0.65
-0.78
-0.8
-0.82
-0.81
-0.81
-0.87
-0.92
Tangible Book Value per Share
- -
- -
0.17
0.08
0.03
-0.03
0.2
0.15
0.25
0.23
0.24
0.23
0.18
0.13
Basic Weighted Avg Shares
63
80
16
17
17
19
20
23
24
24
24
24
24
24
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
1
2
3
3
1
1
Operating Margin (%)
- -
- -
-4,425.99
-1,291.05
-1,882.37
-4,495.5
- -
-29,332.81
-37.05
2.18
16.49
23.97
-58.49
-144.23
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
1
1
1
1
1
- -
Net Income, GAAP
- -
- -
-1
-2
-2
-3
-4
-5
-1
-1
- -
- -
-1
-2
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
-4,337.91
-1,235.25
-3,684.61
-6,929.74
- -
-42,404.6
-140.88
-42.54
-5.92
-3.71
-98.39
-297.93
Working Capital
- -
- -
2
2
-1
-2
3
1
- -
1
1
-4
-5
-5
LT Debt
- -
- -
1
2
2
2
2
5
8
9
9
4
4
2
Total Equity
- -
- -
3
1
1
2
7
6
6
6
6
6
4
3
Return on Invested Capital (%)
- -
1,008.08
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-0.38
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Jun'24
Sep'24
Dec'25
ST Debt
5
5
5
LT Borrowings
- -
- -
- -
LT Finance Leases
4
4
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
24
24
24
Market Capitalization
1
1
1

Working Capital

FRC

in mil. unless spec.
Jun'24
Sep'24
Dec'25
Total Current Assets
1
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
1
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
5
5
5
Payables & Accruals
- -
- -
- -
ST Debt
5
5
5
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
33.12%
-5.68%
-21.98%
Free Cash Flow
-83.37%
-256.88%
-489.44%
Net Income, GAAP
119.13%
206.93%
1,223.76%
Sales/Revenue/Turnover
- -
907.69%
-50.05%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
1
1
1
- -
3
2024
- -
- -
- -
- -
1
2025
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
-0.01
-0.01
-0.02
- -
-0.05
2025
-0.05
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Timothy Ryan Keogh
Full Time Employees
3
Sector
Real Estate
Industry
Real Estate - Services
Address
1555 Blake Street Denver CO United States of America 80202
IPO Date
Jul 10, 2014
Business
AmeriCann, Inc. (OTCQB: ACAN) designs, develops, leases and operates sustainable cannabis cultivation, processing and manufacturing facilities in the United States, utilizing its proprietary Cannopy System that combines traditional horticulture, lean manufacturing and regulatory compliance for efficient production of medical and adult-use cannabis; the company provides real estate acquisition and development services tailored for cannabis operations, licensing procurement assistance in competitive state processes, nationwide support networks of industry leaders and infused product formulation support including beverages, edibles, topicals and concentrates. Its flagship Massachusetts Cannabis Center in Freetown, Massachusetts, comprises a planned one million square feet of greenhouse cultivation and processing space across a 52.6-acre site, with the initial 30,000-square-foot Building 1 operational since 2020 for cultivation, extraction via CO2 and ethanol methods, and product manufacturing leased to licensed operators. Founded in 2010 and headquartered at 1555 Blake Street, Unit 502, Denver, Colorado, AmeriCann targets regulated markets serving dispensaries, patients and consumers through its Preferred Partner Program. The company reports four consecutive quarters of positive net income as of early 2023, alongside record fiscal year-end revenue and EBITDA growth; it secured a Host Community Agreement in Freetown in late 2024, hired Campanelli Construction as general contractor for facility expansions and launched national brand 1906 products at the Massachusetts Cannabis Center in 2021, while pursuing opportunities in California, Pennsylvania and Florida with $2 million in equity financing.